MagSense™ Pre-Clinical Study Presented at 2018 SABCS
On Saturday, December 8, 2018, Marie Zhang, PhD presented the poster "Detection of HER2 Positive Tumor Cells Using Functionalized Iron Oxide Nanoparticles" at…
MagSense™ Technology at ASCO 2018 Annual Meeting
The ASCO 2018 Annual Meeting abstract, "Detection and measurement of HER2+ breast cancer cells using tumor-targeted iron oxide nanoparticles and magnetic…
Imagion Biosystems Announces MD Anderson Cancer Center Takes Equity Stake
click image to download announcement Imagion Biosystems Limited (ASX:IBX), a company dedicated to improving healthcare through the earlier detection of cancer,…
Comment on US Preventive Services Task Force Recommendation Statement, "Screening for Ovarian Cancer"
This article represents the viewpoint of management. Background The worldwide incidence of ovarian cancer is 12.6 per 100,000 women. In the year 2006, ovarian…
Magnetic Relaxometry at the 2017 AACR Meeting
This year's Annual Meeting of the American Association for Cancer Research was held April 1-5 in Washington, D.C. The theme of this year's meeting was…
New Nanoparticle Technologies Arise from MD Anderson Collaboration
Rebeca Romero Aburto PhD is an Imagion Biosystems research collaborator and a post-doctoral fellow at the University of Texas MD Anderson Cancer Center. As an…